Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Asb2α-Filamin A Axis Is Essential for Actin Cytoskeleton Remodeling During Heart Development.

Métais A, Lamsoul I, Melet A, Uttenweiler-Joseph S, Poincloux R, Stefanovic S, Valière A, Gonzalez de Peredo A, Stella A, Burlet-Schiltz O, Zaffran S, Lutz PG, Moog-Lutz C.

Circ Res. 2018 Mar 16;122(6):e34-e48. doi: 10.1161/CIRCRESAHA.117.312015. Epub 2018 Jan 26.

PMID:
29374072
2.

Substrates of the ASB2α E3 ubiquitin ligase in dendritic cells.

Spinner CA, Uttenweiler-Joseph S, Metais A, Stella A, Burlet-Schiltz O, Moog-Lutz C, Lamsoul I, Lutz PG.

Sci Rep. 2015 Nov 5;5:16269. doi: 10.1038/srep16269.

3.

Cullin 5-RING E3 ubiquitin ligases, new therapeutic targets?

Lamsoul I, Uttenweiler-Joseph S, Moog-Lutz C, Lutz PG.

Biochimie. 2016 Mar;122:339-47. doi: 10.1016/j.biochi.2015.08.003. Epub 2015 Aug 4. Review.

PMID:
26253693
4.

Phosphorylation of serine 323 of ASB2α is pivotal for the targeting of filamin A to degradation.

Zakaria R, Lamsoul I, Uttenweiler-Joseph S, Erard M, Monsarrat B, Burlet-Schiltz O, Moog-Lutz C, Lutz PG.

Cell Signal. 2013 Dec;25(12):2823-30. doi: 10.1016/j.cellsig.2013.09.011. Epub 2013 Sep 15.

PMID:
24044920
5.

Deciphering the ubiquitin proteome: Limits and advantages of high throughput global affinity purification-mass spectrometry approaches.

Polge C, Uttenweiler-Joseph S, Leulmi R, Heng AE, Burlet-Schiltz O, Attaix D, Taillandier D.

Int J Biochem Cell Biol. 2013 Oct;45(10):2136-46. doi: 10.1016/j.biocel.2013.05.031. Epub 2013 Jun 10. Review.

PMID:
23764619
6.

Quantitative proteomic analysis to decipher the differential apoptotic response of bortezomib-treated APL cells before and after retinoic acid differentiation reveals involvement of protein toxicity mechanisms.

Uttenweiler-Joseph S, Bouyssié D, Calligaris D, Lutz PG, Monsarrat B, Burlet-Schiltz O.

Proteomics. 2013 Jan;13(1):37-47. doi: 10.1002/pmic.201200233. Epub 2012 Dec 4.

PMID:
23135970
7.

Muscle actin is polyubiquitinylated in vitro and in vivo and targeted for breakdown by the E3 ligase MuRF1.

Polge C, Heng AE, Jarzaguet M, Ventadour S, Claustre A, Combaret L, Béchet D, Matondo M, Uttenweiler-Joseph S, Monsarrat B, Attaix D, Taillandier D.

FASEB J. 2011 Nov;25(11):3790-802. doi: 10.1096/fj.11-180968. Epub 2011 Jul 15.

PMID:
21764995
8.

Diagnostic value and prognostic significance of plasmatic proteasome level in patients with melanoma.

Henry L, Lavabre-Bertrand T, Douche T, Uttenweiler-Joseph S, Fabbro-Peray P, Monsarrat B, Martinez J, Meunier L, Stoebner PE.

Exp Dermatol. 2010 Dec;19(12):1054-9. doi: 10.1111/j.1600-0625.2010.01151.x. Epub 2010 Aug 12.

PMID:
20707810
9.

Proteasome inhibitor-induced apoptosis in acute myeloid leukemia: a correlation with the proteasome status.

Matondo M, Bousquet-Dubouch MP, Gallay N, Uttenweiler-Joseph S, Recher C, Payrastre B, Manenti S, Monsarrat B, Burlet-Schiltz O.

Leuk Res. 2010 Apr;34(4):498-506. doi: 10.1016/j.leukres.2009.09.020. Epub 2009 Oct 6.

PMID:
19811823
10.

A label-free quantitative proteomics strategy to identify E3 ubiquitin ligase substrates targeted to proteasome degradation.

Burande CF, Heuzé ML, Lamsoul I, Monsarrat B, Uttenweiler-Joseph S, Lutz PG.

Mol Cell Proteomics. 2009 Jul;8(7):1719-27. doi: 10.1074/mcp.M800410-MCP200. Epub 2009 Apr 17.

11.

Affinity purification strategy to capture human endogenous proteasome complexes diversity and to identify proteasome-interacting proteins.

Bousquet-Dubouch MP, Baudelet E, Guérin F, Matondo M, Uttenweiler-Joseph S, Burlet-Schiltz O, Monsarrat B.

Mol Cell Proteomics. 2009 May;8(5):1150-64. doi: 10.1074/mcp.M800193-MCP200. Epub 2009 Feb 3.

12.

Toward a full characterization of the human 20S proteasome subunits and their isoforms by a combination of proteomic approaches.

Uttenweiler-Joseph S, Claverol S, Sylvius L, Bousquet-Dubouch MP, Burlet-Schiltz O, Monsarrat B.

Methods Mol Biol. 2008;484:111-30. doi: 10.1007/978-1-59745-398-1_8.

PMID:
18592176
13.

Scaled-down purification protocol to access proteomic analysis of 20S proteasome from human tissue samples: comparison of normal and tumor colorectal cells.

Ducoux-Petit M, Uttenweiler-Joseph S, Brichory F, Bousquet-Dubouch MP, Burlet-Schiltz O, Haeuw JF, Monsarrat B.

J Proteome Res. 2008 Jul;7(7):2852-9. doi: 10.1021/pr8000749. Epub 2008 May 30.

PMID:
18510353
14.

Purification and proteomic analysis of 20S proteasomes from human cells.

Bousquet-Dubouch MP, Uttenweiler-Joseph S, Ducoux-Petit M, Matondo M, Monsarrat B, Burlet-Schiltz O.

Methods Mol Biol. 2008;432:301-20. doi: 10.1007/978-1-59745-028-7_21.

PMID:
18370027
15.

Effect of long-term exposure of SH-SY5Y cells to morphine: a whole cell proteomic analysis.

Neasta J, Uttenweiler-Joseph S, Chaoui K, Monsarrat B, Meunier JC, Moulédous L.

Proteome Sci. 2006 Dec 21;4:23.

16.

Further insight into S-adenosylmethionine-dependent methyltransferases: structural characterization of Hma, an enzyme essential for the biosynthesis of oxygenated mycolic acids in Mycobacterium tuberculosis.

Boissier F, Bardou F, Guillet V, Uttenweiler-Joseph S, Daffé M, Quémard A, Mourey L.

J Biol Chem. 2006 Feb 17;281(7):4434-45. Epub 2005 Dec 15.

17.

An enzymatic cascade of Rab5 effectors regulates phosphoinositide turnover in the endocytic pathway.

Shin HW, Hayashi M, Christoforidis S, Lacas-Gervais S, Hoepfner S, Wenk MR, Modregger J, Uttenweiler-Joseph S, Wilm M, Nystuen A, Frankel WN, Solimena M, De Camilli P, Zerial M.

J Cell Biol. 2005 Aug 15;170(4):607-18.

18.

Long-term morphine treatment enhances proteasome-dependent degradation of G beta in human neuroblastoma SH-SY5Y cells: correlation with onset of adenylate cyclase sensitization.

Moulédous L, Neasta J, Uttenweiler-Joseph S, Stella A, Matondo M, Corbani M, Monsarrat B, Meunier JC.

Mol Pharmacol. 2005 Aug;68(2):467-76. Epub 2005 May 18.

PMID:
15901846
19.

A quantitative proteomic approach using two-dimensional gel electrophoresis and isotope-coded affinity tag labeling for studying human 20S proteasome heterogeneity.

Froment C, Uttenweiler-Joseph S, Bousquet-Dubouch MP, Matondo M, Borges JP, Esmenjaud C, Lacroix C, Monsarrat B, Burlet-Schiltz O.

Proteomics. 2005 Jun;5(9):2351-63.

PMID:
15887188
20.

The Rab5 effector Rabankyrin-5 regulates and coordinates different endocytic mechanisms.

Schnatwinkel C, Christoforidis S, Lindsay MR, Uttenweiler-Joseph S, Wilm M, Parton RG, Zerial M.

PLoS Biol. 2004 Sep;2(9):E261. Epub 2004 Aug 24.

21.

APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment.

Miaczynska M, Christoforidis S, Giner A, Shevchenko A, Uttenweiler-Joseph S, Habermann B, Wilm M, Parton RG, Zerial M.

Cell. 2004 Feb 6;116(3):445-56.

22.

Association of phospholamban with a cGMP kinase signaling complex.

Koller A, Schlossmann J, Ashman K, Uttenweiler-Joseph S, Ruth P, Hofmann F.

Biochem Biophys Res Commun. 2003 Jan 3;300(1):155-60.

PMID:
12480535
23.

Lysine and polyamines are substrates for transglutamination of Rho by the Bordetella dermonecrotic toxin.

Schmidt G, Goehring UM, Schirmer J, Uttenweiler-Joseph S, Wilm M, Lohmann M, Giese A, Schmalzing G, Aktories K.

Infect Immun. 2001 Dec;69(12):7663-70.

24.

Matrix-assisted laser desorption/ionization quadrupole time-of-flight mass spectrometry: an elegant tool for peptidomics.

Verhaert P, Uttenweiler-Joseph S, de Vries M, Loboda A, Ens W, Standing KG.

Proteomics. 2001 Jan;1(1):118-31.

PMID:
11680891
25.

Automated de novo sequencing of proteins using the differential scanning technique.

Uttenweiler-Joseph S, Neubauer G, Christoforidis S, Zerial M, Wilm M.

Proteomics. 2001 May;1(5):668-82.

PMID:
11678036
26.

Purification and characterization of a soluble bioactive amino-terminal extracellular domain of the human thyrotropin receptor.

Cornelis S, Uttenweiler-Joseph S, Panneels V, Vassart G, Costagliola S.

Biochemistry. 2001 Aug 21;40(33):9860-9.

PMID:
11502179
27.

The defensin peptide of the malaria vector mosquito Anopheles gambiae: antimicrobial activities and expression in adult mosquitoes.

Vizioli J, Richman AM, Uttenweiler-Joseph S, Blass C, Bulet P.

Insect Biochem Mol Biol. 2001 Mar 1;31(3):241-8.

PMID:
11167093
28.

Rabenosyn-5, a novel Rab5 effector, is complexed with hVPS45 and recruited to endosomes through a FYVE finger domain.

Nielsen E, Christoforidis S, Uttenweiler-Joseph S, Miaczynska M, Dewitte F, Wilm M, Hoflack B, Zerial M.

J Cell Biol. 2000 Oct 30;151(3):601-12.

29.

Insect immunity. Isolation from the lepidopteran Heliothis virescens of a novel insect defensin with potent antifungal activity.

Lamberty M, Ades S, Uttenweiler-Joseph S, Brookhart G, Bushey D, Hoffmann JA, Bulet P.

J Biol Chem. 1999 Apr 2;274(14):9320-6.

30.

Differential display of peptides induced during the immune response of Drosophila: a matrix-assisted laser desorption ionization time-of-flight mass spectrometry study.

Uttenweiler-Joseph S, Moniatte M, Lagueux M, Van Dorsselaer A, Hoffmann JA, Bulet P.

Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11342-7.

31.

Differential display of peptides induced during the immune response of Drosophila: a matrix-assisted laser desorption ionization time-of-flight mass spectrometry study.

Bulet P, Uttenweiler-Joseph S, Moniatte M, Van Dorsselaer A, Hoffmann JA.

J Protein Chem. 1998 Aug;17(6):528-9. No abstract available.

PMID:
9723735
32.

A drosomycin-GFP reporter transgene reveals a local immune response in Drosophila that is not dependent on the Toll pathway.

Ferrandon D, Jung AC, Criqui M, Lemaitre B, Uttenweiler-Joseph S, Michaut L, Reichhart J, Hoffmann JA.

EMBO J. 1998 Aug 10;17(5):1217-27.

Supplemental Content

Loading ...
Support Center